EDMONTON, Alberta, July 27 /PRNewswire-FirstCall/ -- Medical Services International Inc (OTC:MSITF) is pleased to announce that the test results of the comprehensive testing of its VScan Tuberculosis (TB) test kit and its Hepatitis C test kit were excellent. As a result, the Company will be filing the appropriate documentation with regulatory authorities to apply for CE approval for the Tuberculosis and Hepatitis C test kits. Currently in Europe, the Company has been receiving regulatory approval on a country by country basis. Approval by the European Union will mean that two more kits can be marketed in 26 additional countries. Marketing studies show that there is a significant demand for both the VScan Tuberculosis (TB) test kit and the Hepatitis C test kit. The Company anticipates that this will substantially increase its yearly test kit volume and subsequent cashflow. About VScan The VScan rapid test kit is a single use, disposable, accurate, cost effective, easy to use, test for the screening of HIV 1&2, Hepatitis B&C, Tuberculosis (TB), Dengue Fever, West Nile, Syphilis, Malaria and Prostate Cancer. The kits cannot be sold in Canada. Medical Services International Inc. trades in the United States on the NQB Pinksheets under the symbol "MSITF". For further information, please contact Robert Talbot at (780) 430 6363 or http://www.medicalservicesintl.com/ or http://www.minerva-biotech.com/ . NOTE: Certain statements in this press release are "forward-looking statements" within the meaning of the Private Securities Act of 1995. Such statements involve known and unknown risks, uncertainties and other factors that may cause results to differ materially. Such risks, uncertainties and other factors include but are not limited to new economic conditions, risk in product development, market acceptance of new products and continuing product demand, level of competition and other factors described in Company reports and other filings with regulatory bodies. DATASOURCE: Medical Services International Inc. CONTACT: Robert Talbot of Medical Services International Inc., +1-780-430-6363 Web site: http://www.medicalservicesintl.com/ http://www.minerva-biotech.com/

Copyright